MFY.F - Mochida Pharmaceutical Co., Ltd.

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Mochida Pharmaceutical Co., Ltd.

7, Yotsuya 1-chome
Tokyo 160-8515
81 3 3358 7211

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees1,581

Key Executives

NameTitlePayExercisedYear Born
Mr. Naoyuki MochidaPres & DirectorN/AN/AN/A
Mr. Yoichi KonoExec. MD & DirectorN/AN/AN/A
Keiichi SagisakaSr. Exec. MD & DirectorN/AN/AN/A
Chu SakataSr. Exec. MD & DirectorN/AN/AN/A
Kiyoshi MizuguchiExec. MD & DirectorN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. It provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products. The company has collaboration with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.

Corporate Governance

Mochida Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.